I agree that JAMA was/is significant, and it is a landmark paper, but it has been ages since JAMA considering the lightning-fast evolution of immunotherapy—a lot has developed since JAMA!
Today, we have combos to consider and combos are a whole new ballgame! Our fuddy buddies are really going to have to step up their game as combo data emerge from UCLA and Roswell while additional combo studies soon commence!
Market Data 
Markets 
AI
